List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 10543 studies with search of:   "Placebo"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Placebo Effects on Blood Pressure
Condition: Blood Pressure
Interventions: Other: Placebo with BP dec (written form);   Other: Placebo with BP dec (doctor);   Other: Placebo with BP inc (written);   Other: Placebo with BP inc (doctor);   Other: Placebo info given (written);   Other: Placebo info given (doc)
2 Completed A Placebo-Controlled Prospective Study to Evaluate Flushing in Subjects Administered Niaspan® Plus Aspirin for Six Weeks
Condition: Dyslipidemia
Interventions: Drug: Niaspan plus aspirin;   Drug: Niaspan plus aspirin placebo;   Drug: Niaspan placebo/aspirin placebo
3 Recruiting DermaVir Patch (LC002) in HIV-1 Infected Treatment-naïve Patients
Condition: HIV Infections
Interventions: Biological: DermaVir Patch;   Biological: DermaVir Placebo;   Biological: DermaVir Patch;   Biological: DermaVir Placebo;   Biological: DermaVir Patch;   Biological: DermaVir Placebo
4 Completed Trial Comparing Effects of Xyrem Taken Orally and Modafinil With Placebo in Treating Daytime Sleepiness in Narcolepsy
Condition: Narcolepsy
Interventions: Drug: Xyrem + Modafinil Placebo;   Drug: Xyrem Placebo + Modafinil Placebo;   Drug: Xyrem Placebo + Modafinil at established dose;   Drug: Xyrem + Modafinil at established dose
5 Recruiting Botulinum Toxin A for the Treatment of Chronic Lumbar Back Pain
Condition: Chronic Low Back Pain
Interventions: Drug: Botulinum Toxin A / Placebo;   Drug: Botulinum Toxin A / Botulinum Toxin A;   Drug: Placebo / Botulinum Toxin A;   Drug: Placebo / Placebo
6 Completed A Randomized, Placebo Controlled Study to Determine the Efficacy and Speed of a Nasal Spray in Allergen Induced Seasonal Allergic Rhinitis
Condition: Seasonal Allergic Rhinitis
Interventions: Drug: Azelastine and placebo;   Drug: Loratadine and Placebo;   Drug: Cetirizine and Placebo;   Drug: Placebo and Placebo (spray and Tablet)
7 Not yet recruiting A Phase 3 Study Comparing 2 Doses of CP-690,550 vs. Placebo for Treatment of Rheumatoid Arthritis
Condition: Arthritis, Rheumatoid
Interventions: Drug: CP 690,550;   Drug: CP 690,550;   Drug: Placebo;   Drug: Placebo;   Drug: Placebo;   Drug: Placebo
8 Not yet recruiting Safety and Effectiveness of Tenofovir 1% Gel, Tenofovir Disproxil Fumarate, and Emtricitabine/Tenofovir Disoproxil Fumarate Tablets in Preventing HIV in Women
Condition: HIV Infections
Interventions: Drug: Emtricitabine/tenofovir disoproxil fumarate;   Drug: Emtricitabine/tenofovir disoproxil fumarate placebo;   Drug: Tenofovir disoproxil fumarate;   Drug: Tenofovir disoproxil fumarate placebo;   Drug: Tenofovir 1% vaginal gel;   Drug: Tenofovir placebo
9 Recruiting HALT Progression of Polycystic Kidney Disease (HALT PKD)
Condition: Kidney, Polycystic
Interventions: Drug: Lisinopril and Placebo;   Drug: Lisinopril and Telmisartan;   Drug: Lisinopril and Telmisartan;   Drug: Lisinopril and Placebo;   Drug: Lisinopril and Telmisartan;   Drug: Lisinopril and Placebo
10 Completed A Study Comparing the Efficacy and Safety of Valdecoxib Plus Parecoxib Versus Valdecoxib Plus Placebo for the Treatment of Pain After Coronary Artery Bypass Surgery
Condition: Pain
Interventions: Drug: Parecoxib Sodium/Valdecoxib;   Drug: Placebo/Valdecoxib;   Other: Placebo/Placebo
11 Enrolling by invitation Anit-Inflammatory and Anti-Oxidative Nutrition in Dialysis Patients
Conditions: Hypoalbuminemia;   Protein-Energy Malnutrition;   Inflammation;   Oxidative Stress;   Chronic Kidney Disease (CKD) Hemodialysis
Interventions: Drug: pentoxiphylline;   Dietary Supplement: Nepro;   Dietary Supplement: anti-inflammatory module (similar to Oxepa);   Drug: Placebo pill imitating pentoxiphylline;   Dietary Supplement: Placebo to imitate Nepro;   Dietary Supplement: Placebo to imitate anti-inflammatory module (similar to Oxepa)
12 Completed Safety and Efficacy of Adalimumab to Methotrexate and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis
Condition: Psoriasis
Interventions: Drug: adalimumab;   Drug: MTX;   Drug: placebo adalimumab, placebo MTX
13 Completed First Safety Study in Humans of a Single Dose of CPG 52364
Condition: Healthy Volunteers
Interventions: Drug: Placebo Comparator: Cohort 1 Placebo;   Drug: 52364 3 mg;   Drug: Placebo Comparator: Cohorts 2, 3, 4 & 5 Two subjects each arm will be assigned to receive placebo;   Drug: 52364 10 mg;   Drug: 52364 30 mg;   Drug: 52364 100 mg;   Drug: 52364 1 mg
14 Recruiting Regulation of Cortisol Metabolism and Fat Patterning
Conditions: Obesity;   Menopause
Interventions: Drug: Placebo injection;   Drug: Depo Lupron/Aromatase inhibitor;   Drug: Depo Lupron/placebo;   Drug: placebo;   Drug: Estrogen cream
15 Not yet recruiting The Effects of Expectation and Knowledge on Rizatriptan and Placebo Treatment of Acute Migraine Headache
Condition: Episodic Migraine
Interventions: Drug: Maxalt;   Drug: placebo pill;   Drug: Maxalt;   Drug: placebo pills;   Drug: Maxalt;   Drug: placebo pills;   Drug: no treatment
16 Active, not recruiting A Trial in Type 2 Diabetes Comparing NN9535 to Placebo and Liraglutide
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: NN9535;   Drug: NN9535;   Drug: NN9535;   Drug: NN9535;   Drug: NN9535;   Drug: NN9535;   Drug: placebo;   Drug: placebo;   Drug: placebo;   Drug: placebo;   Drug: placebo;   Drug: placebo;   Drug: liraglutide;   Drug: liraglutide
17 Recruiting Double Blind, Safety and Immunogenicity Study of Recombinant Botulinum Vaccine A/B
Condition: Healthy Volunteers
Interventions: Biological: Placebo (USP sterile saline for injection);   Biological: rBV A/B-40 vaccine;   Biological: Placebo (USP sterile saline for injection);   Biological: rBV A/B-40 vaccine
18 Terminated A Phase 2b Study of DIO-902 or DIO-902 Placebo in Addition to Metformin and Atorvastatin or Atorvastatin Placebo for Type 2 Diabetes
Condition: Type 2 Diabetes
Interventions: Drug: DIO-902;   Drug: DIO-902;   Drug: DIO-902;   Drug: DIO-902 placebo;   Drug: DIO-902;   Drug: DIO-902;   Drug: DIO-902;   Drug: DIO-902 placebo
19 Completed ACT-078573 in Elderly Subjects With Chronic Primary Insomnia
Condition: Chronic Primary Insomnia
Interventions: Drug: ACT-078573 oral capsules at 25 and 100 mg and matching placebo;   Drug: almorexant and matching placebo;   Drug: almorexant and matching placebo;   Drug: almorexant and matching placebo;   Drug: almorexant and matching placebo;   Drug: almorexant and matching placebo;   Drug: almorexant and matching placebo;   Drug: almorexant and matching placebo;   Drug: almorexant and matching placebo;   Drug: almorexant and matching placebo
20 Active, not recruiting Zonisamide SR Plus Bupropion SR Combination Therapy in Subjects With Obesity
Condition: Obesity
Interventions: Drug: Zonisamide SR placebo plus bupropion SR placebo;   Drug: Zonisamide SR placebo plus bupropion SR 360 mg/day;   Drug: Zonisamide SR 120 mg/day plus bupropion SR placebo;   Drug: Zonisamide SR 360 mg/day plus bupropion SR placebo;   Drug: Zonisamide SR 120 mg/day plus bupropion SR 360 mg/day;   Drug: Zonisamide SR 360 mg/day plus bupropion SR 360 mg/day

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services